Rituximab, Yttrium Y-90 ibritumomab tiuxetan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rituximab, Yttrium Y-90 ibritumomab tiuxetan, covering 2019-08-28 to 2019-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL [Phase 2]